source
- Alnylam partners with Inceptive Nucleics on AI deal that could reach $2 billionAlnylam Pharmaceuticals announced a partnership with Inceptive Nucleics to apply artificial‑intelligence tools to its RNA‑based drug discovery program. The agreement provides an upfront $30 millio…
- Lilly and Boehringer cut German investments amid health-spending overhaulA proposed overhaul of Germany's health-insurance financing is sparking criticism from industry groups. Eli Lilly and Boehringer Ingelheim announced they will reduce their investment programmes in…